Sun Pharmaceutical Industries Ltd sold the manufacturing facility located at Bryan (Ohio, USA) to Nostrum Laboratories Inc. “As a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc for the divestment of the Bryan (Ohio) unit in the US,” said Sun Pharma in a press release.
As a part of the agreement, the Sun Pharma subsidiary has divested this unit as a going concern along with the employees and related products to Nostrum. During the divestment process, Sun Pharma was cognisant that the interests of its employees working in the unit were not compromised.